Skip to content

Released Nov 9, 2022, after the close

10-Q filed Nov 9, 2022, 40 days after period end · 0001628280-22-029246

Q3 2022 · 10-Q
Revenue$56.96M+32.2% vs Q3 2021+19.7% vs Q2 2022
Net Income-$161.19MN/M vs Q3 2021N/M vs Q2 2022
EPS Diluted-$0.17N/M vs Q3 2021N/M vs Q2 2022
Operating Income-$128,583,000N/M
Operating Cash Flowderived-$126,323,000N/M
Free Cash Flowderived-$133,007,000N/M
Margins · derived
Operating margin-225.7%−32.7 pt vs Q3 2021
Net margin-283.0%−59.3 pt vs Q3 2021

What the release said

The release

Same quarter

MetricQ3 2022Q3 2021Q3 2020Q3 2019derived from reported figures
Revenue$56.96M$43.10M$14.65M$4.92M
Net Income-$161.19M-$96.41M-$63.74M-$65.37M
EPS Diluted-$0.17-$0.10-$0.84—

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Zai Lab Ltd · CIK 1704292 · Engraved from SEC EDGAR